NPS Pharma and VIMAC Ventures locate at MaRS, a major new research and enterprise center in Toronto

TORONTO May 17, 2004 Salt Lake City-based NPS Pharmaceuticals and Boston-based VIMAC Ventures announced today that they plan to locate key business and research facilities to the new MaRS (Medical and Related Sciences) Discovery District biosciences research and commercialization hub in downtown Toronto. These firms have selected MaRS as the ideal global destination to pursue research and commercial opportunities in the fast-emerging medical and related technology fields.

MaRS Centre will become the primary location for NPS's research and development activities in Canada while VIMAC, a venture capital firm active in biosciences, will establish a business office in the center for the firm's VIMAC Milestone Medica Fund.

To date, 12 organizations have signed agreements to lease almost 600,000 square feet of the 700,000 square feet available in Phase One of MaRS Centre, including CMDF (Canadian Medical Discoveries Fund), the Hospital for Sick Children, MDS Inc. (MDS Sciex Division), RBC Technology Ventures Inc., RBC Financial Group, University Health Network and the Blueprint Initiative.

"With its proximity to some of the leading minds and institutions in Toronto's bioscience cluster, MaRS is the perfect site for our drug research and development work in Canada," says Dr. Hunter Jackson, Chairman, President and CEO of NPS. "Our presence at MaRS underscores our commitment to research and development in Canada and the importance of this new facility to our future business success."

NPS will initially move approximately 70 researchers into a wet lab facility at MaRS, with plans to add another 50 scientists over time. The company has been mining a wealth of research from the Toronto area for many years.

VIMAC chose MaRS to expand the firm's North American reach because it provides one of the most dynamic opportunities for investment in biosciences, according to Dana Ono, Managing Director, VIMAC Milestone Medica Fund.



Page: 1 2 3 4

Related biology news :

1. Warren Pharmaceuticals publishes results of preclinical evaluation
2. Pharmacogenomics could replace trial-and-error with science from the human genome
3. Cyclis Pharmaceuticals reports studies defining new mechanism for potential cancer therapies
4. Relapse or remission? Pharmacogenomics draws the fine line
5. Pharmaceutical smart bomb targets cancer cells
6. Final results of the two Zevalin pivotal trials in radioimmunotherapy for B cell Non-Hodgkins Lymphoma announced by IDEC Pharmaceuticals
7. Science and Amersham Pharmacia Biotech grand prize: "jumping DNA" discovery explains immune system evolution
8. Pharmaceutical and personal care products: What happens when they enter the environment - an emerging concern
9. Science and Amersham Pharmacia Biotech award Young Scientist Prize
10. Researchers, Regulators, Industry, Consumer Advocates Gather to Discuss Critical Issues Facing the Pharmaceutical Industry
11. Ribozyme Pharmaceuticals, Inc. Demonstrates Potent Activity Of A Ribozyme Targeted Against The Hepatitis C Virus

Post Your Comments:

(Date:6/4/2019)... ... June 04, 2019 , ... Molecular Devices, ... Susan Murphy as the new President of Molecular Devices, replacing Greg Milosevich who ... company, Danaher Corporation. , Since joining Molecular Devices in a scientific engineering role, ...
(Date:6/3/2019)... ... June 03, 2019 , ... Stay on top of current hot topics ... industries. Access to all webinars is free, so be sure to register today to ... Visit http://www.xtalks.com to see our upcoming webinars: , CLINICAL TRIALS , June ...
(Date:5/31/2019)... ... 2019 , ... Join Julie Peacock, Vice President of Product ... June 19, 2019 at 1pm EDT where she will demonstrate how role-based data ... contract research organizations (CROs) can improve collaboration, auditing, document tracking and reporting. , ...
Breaking Biology News(10 mins):
(Date:5/14/2019)... ... May 13, 2019 , ... ... testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is ... redesigned website aims to improve LDA’s ability to communicate directly with the marketplace; ...
(Date:5/4/2019)... ... 03, 2019 , ... Diopsys Inc, the world leader in ... vision test, a new full field electroretinography (ffERG) protocol designed to detect ... Americans will have glaucoma, with black Americans having the highest prevalence rate. This ...
(Date:5/2/2019)... ... May 02, 2019 , ... ... in the greater Boston area. Gone are the days of painful hair transplant ... Robotic Hair Restoration System is the only robotic intelligent solution to offer a ...
(Date:4/16/2019)... , ... April 16, 2019 , ... ... systems, applications, and technology, today announced that Bank South Pacific (BSP), the largest ... RFP process. The bank awarded Fulcrum a contract to deliver a fingerprint-based Know ...
Breaking Biology Technology:
Cached News: